When a child looks fine after COVID but is suddenly exhausted, foggy, short of breath, or no longer coping with school the way they used to, parents often feel something is wrong long before anyone can explain it🧵
This review argues that long COVID in children is real, often underestimated, and important to take seriously - not to create panic, but to help families recognize it early and respond with care and common sense.
This review makes one central point very clearly - long COVID can affect children and teenagers in meaningful ways, even after a mild infection, and even when routine tests do not show anything dramatic.
The authors describe long COVID in young people as a broad, mixed, and often frustrating condition. It does not look the same in every child. Some mainly struggle with exhaustion. Others develop headaches, poor concentration, dizziness, palpitations, chest discomfort, sleep problems, anxiety.
In many cases, symptoms come and go, fluctuate over time, and get worse after physical or mental effort. That unpredictability is one of the reasons families can feel dismissed or confused.
There is no single lab test that can prove long COVID. Doctors usually have to rely on the pattern of symptoms, the timing after infection, the effect on daily life, and the exclusion of other causes. So a child can have normal basic results and still be genuinely unwell. That point really matters, because many parents worry that if tests are normal, the problem must not be real. The review strongly suggests otherwise.
The article highlights fatigue and reduced exercise tolerance as some of the most common problems. This is not just ordinary tiredness. In some children, even a normal school day, a sports practice, or a mentally demanding afternoon can trigger a crash afterward.
The review points to the idea of post-exertional malaise, meaning symptoms can worsen after effort. For parents, this is one of the most practical and important concepts in the whole paper, because it explains why pushing a child too hard can backfire.
Another major issue is brain fog. Children may struggle with memory, concentration, processing information, reading, or finishing tasks. They may seem distracted or slower than before. One especially interesting point in the article is that these problems can sometimes resemble ADHD on the surface.
The review also describes headaches, poor sleep, muscle and joint pain, chest tightness, shortness of breath, chronic cough, palpitations, and dizziness. Some children appear to develop signs of autonomic dysfunction, including POTS, where standing up can trigger a racing heart, weakness, lightheadedness, or even fainting.
The article makes it clear that these symptoms can still be deeply disruptive.
The authors acknowledge that emotional distress, disrupted routines, social isolation, and the broader effects of the pandemic can also shape how children feel and function.
They present long COVID as something that often sits at the intersection of physical symptoms, nervous system changes, immune effects, school stress, sleep disruption, and mental health strain. For parents, that is a much more realistic and useful way to think about it.
The authors discuss possible mechanisms such as immune dysregulation, viral persistence, endothelial dysfunction, microcirculatory changes, and autonomic nervous system involvement.
The review explicitly reports immune abnormalities in children with long COVID, including changes in T and B lymphocytes and an imbalance in regulatory T cells, and it also mentions the possibility of viral reservoirs, endothelial dysfunction, and microcirculatory damage.
There are plausible biological models for why some children continue to feel unwell after infection!
One of the most parent-relevant themes in the review is how much long COVID can affect school performance and participation. A child may physically attend school but still be unable to cope with the cognitive load, noise, pace, social demands, and sustained attention.
They may come home completely drained, struggle to finish homework, or gradually stop being able to keep up.
That is why the article supports school accommodations when needed.
For families, this is one of the clearest signs that the illness is not only about symptoms - it can genuinely reshape a child’s development and daily life.
The review spends time on anxiety, depression, low mood, stress reactions, and even PTSD, especially in children who were severely ill. It also notes that the family can be affected too. Parents may feel helpless, overwhelmed, or traumatized by the uncertainty.
In other words, mental health support may be necessary and helpful without meaning the illness is all in the child’s head.
That distinction is crucial for families, because many parents have encountered exactly that kind of dismissive framing.
The review recommends a targeted, symptom-led evaluation. That means the workup should depend on what is most prominent. If a child mainly has breathing problems, lung testing may be appropriate. If they have palpitations and dizziness, a cardiac or autonomic evaluation may be more relevant. If headaches and cognitive issues dominate, neurological assessment may matter more.
Possible tests mentioned include lung function tests, imaging when indicated, ECG, echocardiography, inflammatory markers, blood work, thyroid tests, and in some cases more advanced evaluations. For suspected POTS, the article mentions standing tests or tilt-table testing.
For children with POTS-like symptoms, the article mentions measures such as hydration, increased salt intake, compression garments, exercise adapted to tolerance, and sometimes medications like beta-blockers, fludrocortisone, midodrine, or ivabradine. But the authors also acknowledge that strong pediatric evidence is still limited.
This is a valuable review because it presents pediatric long COVID as real, varied, imperfectly understood, and deserving of careful, individualized care.
Caliman–Sturdza at al., Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches. tandfonline.com/doi/epdf/10.10…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new large cohort study in Frontiers in Medicine looked at people who developed shingles after COVID-19.
Could shingles after COVID be more than just a painful rash - with possible links to later blood-cancer risk?🧵
The authors used the TriNetX global health network - electronic health records from more than 140 healthcare organizations.
They compared COVID-19 survivors who developed shingles within 1 year with COVID-19 survivors who did not.
After matching, the study compared roughly 29,270 people in each group.
The follow-up 3 years.
The authors were not only looking at short-term symptoms, but later infectious and blood-related outcomes.
A new narrative review in Communications Medicine sums up where the field stands on long COVID.
Not as one single, uniform diagnosis, but as a complex, multisystem condition after SARS2 infection🧵
Its value is in the synthesis. It brings together immunology, neurology, vascular biology, metabolism, and clinical medicine into one framework.
The review covers prevalence, pathophysiology, biomarkers, treatment strategies, and future research directions. It is a broad interpretation of the current literature.
A heart attack after COVID may not look like the classic heart attack we usually imagine.
A new core-lab study of patients with NSTEMI + COVID-19 suggests something more diffuse. Not just one blocked artery, but a blood-clotting and vessel inflammation problem🧵
First, two key terms.
STEMI is the type of heart attack where the ECG shows ST-segment elevation. It often means a major coronary artery is suddenly blocked.
NSTEMI is a heart attack without that classic ST elevation. It can be less obvious on ECG, but it is not minor.
So STEMI is often like a main pipe suddenly being blocked.
NSTEMI can be more complex. Partial blockage, smaller clots, multiple narrowed vessels, poor microvascular flow, or the heart being stressed by illness.
But COVID can add another layer.
For 2025, the societal cost of Long COVID and ME/CFS in Germany is estimated at €64.4 billion - about 1.44% of GDP.
For Czechia, this would roughly translate to around CZK 120 billion per year if we apply the same share of GDP - 1.44% of the Czech economy.
A simple population-based conversion would produce a higher number (200 billion), but that is an overestimate.
This should matter to you, @strakovka.
Because this is what poor public health policy costs. Ignoring prevention, ventilation, surveillance, post-COVID care, and the long-term damage caused by repeated infections.
A new systematic review looked at what happens to the heart after COVID - not during the acute infection, but months later.
The key point:
A normal ejection fraction does not always mean the heart is completely unaffected.🧵
In people assessed more than 12 weeks after PCR confirmed COVID - especially those with persistent cardiopulmonary symptoms - there is evidence of subtle, and sometimes persistent, cardiac involvement.
This may show up as
higher BNP/NT-proBNP
reduced LV-GLS
abnormalities on cardiac MRI
while LVEF often remains normal
Exertion and PEM.
A new paper studied people with long COVID using a 2-day (!) submaximal CPET protocol, combined with NIRS measurement on the calf muscle.
The authors looked at what happens to breathing, performance, and muscle oxygenation during repeated exertion🧵
The key finding.
In the long COVID group, muscle tissue oxygen saturation (TSI%) initially increased during exercise, but it did not stay elevated for as long as it did in controls. (Thomas 2026)
On day 2, this pattern was even worse. In long COVID, TSI% stayed above resting levels for a shorter period, while controls maintained elevated muscle oxygenation more effectively during exercise.